Ownership history in UBS Group AG · 4 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CHINA SXT PHARMACEUTICALS IN (SXTC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 222 | +122 | +122.0% | 0.00% | $356 | $240.00 |
| 2025 Q3 | REDUCED | 100 | -62,499 | -99.8% | 0.00% | $157 | $235.50 |
| 2025 Q2 | ADDED | 62,599 | +57,329 | +1087.8% | 0.00% | $108K | $259.50 |
| 2025 Q1 | INITIATED | 5,270 | — | — | 0.00% | $13K | $374.25 |
As of 2025 Q4 — sorted by position size